DE69430295D1 - Pulver zur nasalen Verabreichung peptidischer oder proteinischer Arzneistoffe - Google Patents

Pulver zur nasalen Verabreichung peptidischer oder proteinischer Arzneistoffe

Info

Publication number
DE69430295D1
DE69430295D1 DE69430295T DE69430295T DE69430295D1 DE 69430295 D1 DE69430295 D1 DE 69430295D1 DE 69430295 T DE69430295 T DE 69430295T DE 69430295 T DE69430295 T DE 69430295T DE 69430295 D1 DE69430295 D1 DE 69430295D1
Authority
DE
Germany
Prior art keywords
powder
nasal administration
peptide
protein drugs
peptidic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69430295T
Other languages
English (en)
Other versions
DE69430295T2 (de
Inventor
Masahiko Dohi
Yoshihisa Nishibe
Yuji Makino
Yoshiki Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Publication of DE69430295D1 publication Critical patent/DE69430295D1/de
Application granted granted Critical
Publication of DE69430295T2 publication Critical patent/DE69430295T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B60—VEHICLES IN GENERAL
    • B60H—ARRANGEMENTS OF HEATING, COOLING, VENTILATING OR OTHER AIR-TREATING DEVICES SPECIALLY ADAPTED FOR PASSENGER OR GOODS SPACES OF VEHICLES
    • B60H1/00—Heating, cooling or ventilating [HVAC] devices
    • B60H1/00485—Valves for air-conditioning devices, e.g. thermostatic valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF] (Somatoliberin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
DE69430295T 1993-07-30 1994-07-29 Pulver zur nasalen Verabreichung peptidischer oder proteinischer Arzneistoffe Expired - Lifetime DE69430295T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP20692293 1993-07-30
JP23584193 1993-08-30
JP164494 1994-01-12
PCT/JP1994/001257 WO1995003818A1 (fr) 1993-07-30 1994-07-29 Poudre permettant l'administration par voie nasale d'un medicament peptidique ou proteique

Publications (2)

Publication Number Publication Date
DE69430295D1 true DE69430295D1 (de) 2002-05-08
DE69430295T2 DE69430295T2 (de) 2002-10-31

Family

ID=27275015

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69430295T Expired - Lifetime DE69430295T2 (de) 1993-07-30 1994-07-29 Pulver zur nasalen Verabreichung peptidischer oder proteinischer Arzneistoffe

Country Status (9)

Country Link
US (1) US5578324A (de)
EP (1) EP0667163B1 (de)
JP (1) JP2974412B2 (de)
KR (1) KR100327563B1 (de)
AT (1) ATE215377T1 (de)
CA (1) CA2145302C (de)
DE (1) DE69430295T2 (de)
ES (1) ES2171459T3 (de)
WO (1) WO1995003818A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981719A (en) 1993-03-09 1999-11-09 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
WO1995033474A1 (fr) * 1994-06-03 1995-12-14 Tsumura & Co. Composition medicinale
JP3263598B2 (ja) * 1995-11-01 2002-03-04 有限会社ドット 経鼻吸収用生理活性ペプチド組成物
AU722319B2 (en) * 1996-02-27 2000-07-27 Teijin Limited Powdery composition for nasal administration
DK1025859T3 (da) * 1998-08-26 2006-10-16 Teijin Ltd Pulverformige pernasale præparater
CA2488497A1 (en) * 2002-06-11 2003-12-18 The Burnham Institute Neuroprotective synergy of erythropoietin and insulin-like growth factor
US7812120B2 (en) * 2003-03-21 2010-10-12 Par Pharmaceutical, Inc. Nasal calcitonin formulations containing chlorobutanol
JP2008019245A (ja) * 2006-06-15 2008-01-31 Japan Science & Technology Agency ヒューマニン誘導体又は該誘導体と神経向性ペプチドとの融合ペプチドを有効成分として含有する、アルツハイマー病予防・治療用の経鼻投与剤
KR102259110B1 (ko) * 2016-11-28 2021-06-01 포라 가세이 고교 가부시키가이샤 주름 개선제
JP7102658B2 (ja) * 2018-05-29 2022-07-20 ポーラ化成工業株式会社 美白用組成物
JP7102657B2 (ja) * 2018-05-29 2022-07-20 ポーラ化成工業株式会社 シワ改善用組成物
SG11202011525WA (en) * 2018-05-29 2020-12-30 Pola Chem Ind Inc Skin lightening agent

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4258030A (en) * 1979-03-07 1981-03-24 Zeria-Shinyaku Kogyo Kabushiki Kaisha Urokinase preparation for oral administration
DE3514508A1 (de) * 1985-04-22 1986-10-30 Kailash Kumar Prof. Dr. 2359 Lentföhrden Gauri Verwendung von dopamin und dessen ester bei der behandlung von glaukom
JPH01308235A (ja) * 1988-06-03 1989-12-12 Yamanouchi Pharmaceut Co Ltd ヒト成長ホルモン経鼻剤
GB9013448D0 (en) * 1990-06-15 1990-08-08 Sandoz Ltd Pharmaceutical resorption-improved somatostatin compositions,their preparation and use
JPH04235923A (ja) * 1991-01-16 1992-08-25 Kyowa Hakko Kogyo Co Ltd 経鼻投与用製剤
JPH04300817A (ja) * 1991-03-27 1992-10-23 Shiseido Co Ltd 口腔用組成物
JPH0558908A (ja) * 1991-09-05 1993-03-09 Mitsubishi Kasei Corp カルシトニン点鼻用医薬組成物
JP3090353B2 (ja) * 1991-09-17 2000-09-18 旭化成工業株式会社 パラチロイドホルモン類含有経鼻投与用乳剤
JP3047948B2 (ja) * 1992-12-07 2000-06-05 株式会社ツムラ ペプチド類経鼻投与用組成物

Also Published As

Publication number Publication date
KR950703352A (ko) 1995-09-20
KR100327563B1 (ko) 2002-08-24
ATE215377T1 (de) 2002-04-15
JP2974412B2 (ja) 1999-11-10
EP0667163A4 (de) 2000-04-19
EP0667163B1 (de) 2002-04-03
EP0667163A1 (de) 1995-08-16
ES2171459T3 (es) 2002-09-16
WO1995003818A1 (fr) 1995-02-09
DE69430295T2 (de) 2002-10-31
US5578324A (en) 1996-11-26
CA2145302A1 (en) 1995-02-09
CA2145302C (en) 2008-10-28

Similar Documents

Publication Publication Date Title
DE69430295D1 (de) Pulver zur nasalen Verabreichung peptidischer oder proteinischer Arzneistoffe
FI953467A (fi) Aminohappojohdannaisia, näitä yhdisteitä sisältävät lääkeaineet ja menetelmä niiden valmistamiseksi
ATE155486T1 (de) Zyklische peptide und ihre verwendung
AU8772691A (en) New compounds
DK366889A (da) Peptidderivat
ATE194846T1 (de) Zyklische antimikrobielle peptide und deren herstellung
DE69323337D1 (de) Derivate des Parathormons
FR2710340B1 (fr) Dérivés peptidiques de l'alpha-MSH et leur application .
DE69524609T2 (de) Verzoegerte freisetzung von peptiden aus pharmazeutischen zusammensetzungen
AU589939B2 (en) Medical composition for injection containing a spergualin as active ingredient and process for preparing the same
NO870441D0 (no) Farmasoeytiske preparatformer for stabilisering av alfa- interferon.
PT1079849E (pt) Utilizacao de proteinas hmg para a preparacao de medicamentos com actividade citotoxica
NO894720D0 (no) Farmasoeytisk aktivt protein.
AU5162196A (en) Novel peptides and remedy for bone diseases containing the same as active ingredient
EA199700302A1 (ru) Биологически активные уреидо-производные, полезные при лечении рассеянного склероза
DK628388D0 (da) Vincristinholdigt produkt
BR9813037A (pt) Composto, processo para sua preparação, uso do mesmo, preparação farmacêutica, e, combinação desta com pelo menos uma outra substância ativa
KR900003198A (ko) 신규 글루탐산 유도체, 그의 염, 그의 제조방법, 이들의 의약품으로서의 용도 및 이들을 함유한 조성물
IT1216103B (it) Peptidi ad attivita' farmaceutica.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition